Progressive supranuclear palsy presenting with corticobasal syndrome: a case report
Objective: Clinical description and interpretation of complementary diagnostic exams of a patient with probable PSP with corticobasal syndrome phenotype (PSP-CBS). Background: Underlying pathologies of CBS…[11C]PK11195 PET in Alzheimer’s disease and progressive supranuclear palsy: the NIMROD study
Objective: Here we test whether the intensity and regional distribution of neuro-inflammation differs between Alzheimer's disease (AD), Progressive Supranuclear Palsy (PSP) and controls; and whether neuro-inflammation…Movement Disorder Society – Clinical Diagnostic Criteria for Progressive Supranuclear Palsy
Objective: The International Parkinson and Movement Disorders Society-endorsed PSP Study Group aimed to provide an evidence- and consensus-based revision of the clinical diagnostic criteria for…Aspects of Quality of Life in MSA and PSP
Objective: The aim of this study was exploring the correlation between disease severity and QoL in PSP and MSA. Background: MSA and PSP are atypical Parkinsonian disorders that…To Study the Role of Biomarkers DJ-1 and Apo A1 in Idiopathic Parkinson’s Disease and Parkinson Plus Syndromes in Indian Population
Objective: To study the role of serum DJ-1 and Apo A1 in the diagnosis and differentiation of Idiopathic Parkinson Disease (IPD) and Parkinson Plus Syndromes(PPS)…Results of a Phase 1, Single Ascending Dose, Placebo-Controlled Study of ABBV-8E12 in Patients with Progressive Supranuclear Palsy and Phase 2 Study Design
Objective: To present the results of a phase 1 study of ABBV-8E12 in subjects with Progressive Supranuclear Palsy (PSP) and design of a phase 2…Reversible progressive supranuclear palsy-mimic induced by risperidone
Objective: To report a patient who presented with a progressive supranuclear palsy (PSP)-like syndrome while receiving risperidone that disappeared after drug withdrawal. Background: Drugs that…Can the level of CSF Neurofilament Light Chain predict disease progression in Progressive Supranuclear Palsy?
Objective: To investigate whether the level of CSF Neurofilament Light Chain (NFL) can predict the speed of disease progression in patients with Progressive Supranuclear Palsy…The basal ganglia muscarine receptors impairment in progressive supranuclear palsy
Objective: To measure muscarinic M2 and M4 receptors in the basal ganglia in PSP. Background: Progressive supranuclear palsy is a nuerodegenerative Parkinson's plus syndrome. This…Atypical Parkinsonian disorders: Insights for a differential diagnosis through the analysis of oculomotor profile in MSA, PSP and CBD patients
Objective: To determine peculiar changes in oculomotor profile that may help in distinguishing atypical parkinsonism with overlapping clinical features. Background: Atypical Parkinsonian disorders (APDs) include…
- « Previous Page
- 1
- …
- 35
- 36
- 37
- 38
- 39
- …
- 42
- Next Page »